Skip to content
★ Sign in to follow
TA

Thomas A. Boyd

Progenics Pharmaceuticals Inc
Total declarations
99
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (26 ops.)
€891k

Latest filing published 06 Jul 2010 for PROGENICS PHARMACEUTICALS INC, €9,448.

Insider track record

Disclosed buys
0
Disclosed sells
26
Signal history

No signal scores available.

Thomas A. Boyd: trading record in brief

Thomas A. Boyd appears in our data through filings on Progenics Pharmaceuticals Inc shares, published by SEC (Form 4). We count 99 filings; the first trade dates from 3 January 2006 and the latest from 1 July 2010.

On the market, this insider has only sold: 26 sales, €891k in total. Other entries cover 26 share grants and 43 option exercises. 2010 to date brings no purchases and 1 sale.

The newest entry dates from 6 July 2010: an option exercise of €9,448, in Progenics Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Thomas A. Boyd

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations84 total

25 of 84 declarations